ClearPoint Neuro (CLPT) Enterprise Value (2012 - 2026)

ClearPoint Neuro has disclosed Enterprise Value across 15 years of filings, most recently posting $514.8 million for Q2 2026.

• In Q2 2026, Enterprise Value rose 72.84% year-over-year to $514.8 million; the TTM figure through Jun 2026 stood at $514.8 million (up 72.84% YoY), while the FY2025 annual figure was $355.8 million, down 12.06% from the prior year.
• Enterprise Value came in at $514.8 million for Q2 2026 at ClearPoint Neuro, up from $237.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $581.2 million in Q3 2025 to a low of $99.0 million in Q3 2023.
• Average Enterprise Value over 5 years is $260.7 million, with a median of $225.3 million recorded in 2022.
• Year-over-year, Enterprise Value plunged 53.59% in 2023 and jumped 190.51% in 2024.
• Over 5 years, Enterprise Value stood at $170.7 million in 2022, then retreated by 15.48% to $144.3 million in 2023, then surged by 180.52% to $404.7 million in 2024, then retreated by 12.06% to $355.8 million in 2025, then soared by 44.66% to $514.8 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $514.8 million in Q2 2026, $237.3 million in Q1 2026, and $355.8 million in Q4 2025.